Preferential Expression of Programmed Death Ligand 1 Protein in Tumor-Associated Macrophages and Its Potential Role in Immunotherapy for Hepatocellular Carcinoma

Preferential Expression of Programmed Death Ligand 1 Protein in Tumor-Associated Macrophages and Its Potential Role in Immunotherapy for Hepatocellular Carcinoma

A predictive biomarker of immune checkpoint inhibitor (ICI)-based treatments in hepatocellular carcinoma (HCC) has not been clearly demonstrated. In this study, we focused on the infiltration and programmed death ligand 1 (PD-L1) expression of tumor-associated macrophages (TAMs) in the tumor microen...

Full description

Bibliographic Details
Main Authors: Dong-Jun Park, Pil-Soo Sung, Gil-Won Lee, Sungwoo Cho, Sung-Min Kim, Byung-Yoon Kang, Wonhee Hur, Hyun Yang, Soon-Kyu Lee, Sung-Hak Lee, Eun-Sun Jung, Chang-Ho Seo, Joseph Ahn, Ho-Joong Choi, Young-Kyoung You, Jeong-Won Jang, Si-Hyun Bae, Jong-Young Choi, Seung-Kew Yoon
Format: Article
Language:English
Published: MDPI AG 2021-04-01
Series:International Journal of Molecular Sciences
Subjects:
hepatocellular carcinoma
tumor-associated macrophages
PD-L1
anti-PD-L1
Online Access:https://www.mdpi.com/1422-0067/22/9/4710

Internet

https://www.mdpi.com/1422-0067/22/9/4710

Similar Items